Home » Markets » India's Biocon secures approval use drug on coronavirus patients
India's Biocon secures approval use drug on coronavirus patients
Fox Business Flash top headlines for July 10
Fox Business Flash top headlines are here. Check out what’s clicking on FoxBusiness.com.
India’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.
Continue Reading Below
The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in India.